About Hainan Huantai Bio-Pharmaceutical Investment Fund
The firm is a joint venture owned by Hainan Haiyao, Infotech Pacific Ventures, Haikou Creative Venture Capital, Chongqing Jiesheng Investment, and private enterprise Hainan Hanbang International.
Hainan Huantai Bio-Pharmaceutical Investment Fund Headquarter Location
Latest Hainan Huantai Bio-Pharmaceutical Investment Fund News
Mar 11, 2014
Like our Facebook page and follow us now on Twitter @chinamoneypod . Haikou, Hainan province-based Hainan Haiyao says that the company plans to invest RMB122 million ($20 million) in Hainan Huantai Bio-Pharmaceutical Investment Fund for a 48.8% stake, according to a company announcement. The fund is a pharma-focused joint venture launched by Hainan Haiyao and several venture capital firms. Infotech Pacific Ventures and Haikou Creative Venture Capital will each invest RMB50 million into the joint venture, taking a 20% stake each. Other investors include Chongqing Jiesheng Investment and private enterprise Hainan Hanbang International. The JV fund will primarily invest in biological and pharmaceutical related business, with a total size of RMB250 million under management. Be Sociable, Share!